- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Curettage and cryosurgery both effective treatment options for superficial basal cell carcinoma
Sweden: Both curettage and cryosurgery are associated with a high rate of clinical clearance in superficial basal cell carcinoma (sBCC) while wound healing time is faster in curettage, states study results published in The Journal of the European Academy of Dermatology and Venereology
Basal cell carcinoma (BCC) is the most common form of skin cancer amongst humans. Reports on incidence trends confirm a relative increase of superficial BCCs (sBCC) compared to other subtypes. Currently, sBCC has several treatment options but clearance rates with destructive methods have varied greatly.
The most studied methods for sBCC are cryotherapy with or without prior curettage, curettage, and electrodesiccation, while curettage alone has not been extensively evaluated. Factors like physician experience, type of device used, meticulous application, and others affect the efficacy of these treatments. Curettage only (i.e. without subsequent cryosurgery or electrodesiccation) is a simple and quick destructive treatment method used for many benign skin lesions.
In this single-centre noninferiority clinical trial, E.J. Backman, University of Gothenburg, Sweden, and colleagues compared the effectiveness of curettage versus cryosurgery for superficial basal cell carcinoma (sBCC) in terms of overall clinical clearance after treatment.
For the study, in total 228 sBCCs with a diameter of 0.5–2 cm were randomized to either cryosurgery using one freeze-thaw cycle or curettage. At follow-up visits, treatment areas were evaluated regarding the presence of residual tumour after 3–6 months and recurrence after 1 year. Further, wound healing times were also assessed.
Results
• At 3–6 months, no residual tumours were seen in any of the treated areas.
• After 1 year, the clinical clearance rates for curettage and cryosurgery were 95.7% and 100%, respectively. However, the non-inferiority analysis was inconclusive.
• Wound healing times were shorter for curettage (4 weeks) compared to cryosurgery (5 weeks) and cosmesis was similar in both groups
• Overall, patient satisfaction was high after 1 year.
Researchers conclude that both curettage and cryosurgery in a single freeze-thaw cycle show promising 1-year results regarding clinical clearance, whilst curettage reduced the wound healing time. This study provides new evidence for use of simple destructive treatment methods to treat sBCC effectively
The strength of the present study is its precisely described treatment methods but the small size of the study and a short follow-up period present potential weaknesses, so longer follow-up and larger studies are needed to confirm efficacy. Also, studies on specific subtypes of BCCs are recommended by the authors.
Reference:
E.J. Backman,S. Polesie,S. Berglund,M. Gillstedt,A. Sjöholm,M. Modin,J. Paoli First published: 11 May 2022. https://doi.org/10.1111/jdv.18209
BDS
Dr. Hiral patel (BDS) has completed BDS from Gujarat University, Baroda. She has worked in private dental steup for 8years and is currently a consulting general dentist in mumbai. She has recently completed her advanced PG diploma in clinical research and pharmacovigilance. She is passionate about writing and loves to read, analyses and write informative medical content for readers. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751